Evidence map›Paper›PMID 40078315›Full record

ArticleNanotheranostics2025

A miniature low-immunogenic platform for the biosynthesis of self-assembling protein nanoparticles.

Almina I Polinova, Anna V Serkina, Marina V Volkova, Aleksandr A Gorbunov, Evgeniia P Sannikova, Irek I Gubaidullin, Aleksandr S Komolov, Anna V Rybakova, Marina Yu Kopaeva, Konstantin S Plokhikh and 7 more

Abstract read
In one paragraph

Article in Nanotheranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Almina I PolinovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Anna V SerkinaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Marina V VolkovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Aleksandr A GorbunovNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Evgeniia P SannikovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Irek I GubaidullinNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Aleksandr S KomolovNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Anna V RybakovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Marina Yu KopaevaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Konstantin S PlokhikhNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Georgy S PetersNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Artem A ShatilovNational Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, 1115522, Russia.
Alexander A ShtilBlokhin National Medical Research Center of Oncology, Moscow, 115522, Russia.
Galina A PosypanovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Alexander P TrashkovNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Natalia V BulushovaNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.
Dmitry G KozlovNational Research Center «Kurchatov Institute», Moscow, 123182, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NanoparticlesAnimalsFemaleMiceMice, Inbred C57BLOvalbuminPeptidesOvalbuminPeptidesartificial vaccine platformimmunogenicityN-terminal formylmethionineOVA257-280 antigenself-assembling protein nanoparticleself-associating peptidesubunit vaccine

Identifiers

PMID40078315
PMCPMC11898719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.